Paeds Vivas · preventive-and-community-paediatrics
Immunisation principles and national schedule comparison — branching viva
Branching viva on vaccine platforms, valid doses, herd immunity, visit safety and national schedule comparison.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar running a teaching immunisation clinic. The examiner will challenge definitions, validity rules, population protection and cross-country schedule reasoning.
Stem
The examiner moves from definitions to an infant multi-antigen visit, then to measles coverage and regional schedules. [4] [8] [30]
References40ShowHide
- [1]Fine P Herd immunity: a rough guide Clin Infect Dis, 2011.PMID 21427399
- [2]Fine PE Herd immunity: history, theory, practice Epidemiol Rev, 1993.PMID 8174658
- [3]Anderson RM Immunisation and herd immunity Lancet, 1990.PMID 1969023
- [4]National Center for Immunization and Respiratory Diseases General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep, 2011.PMID 21293327
- [5]Wodi AP Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024. MMWR. Morbidity and mortality weekly report, 2024.PMID 38206855
- [6]Wodi AP Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2023. MMWR. Morbidity and mortality weekly report, 2023.PMID 36757872
- [7]Wodi AP Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2021. MMWR. Morbidity and mortality weekly report, 2021.PMID 33571172
- [8]McLean HQ Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013.PMID 23760231
- [9]Tulchinsky TH Measles control in developing and developed countries: the case for a two-dose policy. Bulletin of the World Health Organization, 1993.PMID 8440043
- [10]Colburn NE Measles - Resurgence of an Old Foe. The Medical clinics of North America, 2025.PMID 40185555
- [11]Kiang MV Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US. JAMA, 2025.PMID 40272967
- [12]Amirthalingam G Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet (London, England), 2014.PMID 25037990
- [13]Gkentzi D Maternal vaccination against pertussis: a systematic review of the recent literature. Archives of disease in childhood. Fetal and neonatal edition, 2017.PMID 28468899
- [14]Schillie S Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2018.PMID 29939980
- [15]Cortese MM Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2009.PMID 19194371
- [16]Petrosky E Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR. Morbidity and mortality weekly report, 2015.PMID 25811679
- [17]Meites E Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR. Morbidity and mortality weekly report, 2019.PMID 31415491
- [18]Kobayashi M Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR. Morbidity and mortality weekly report, 2022.PMID 36107786
- [19]Parikh SR The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. The Journal of infection, 2020.PMID 32504737
- [20]Albers AN Invalid Vaccine Doses Among Children Aged 0 to 35 Months: 2011 to 2020. Pediatrics, 2025.PMID 39788151
- [21]Stokley S Evaluation of invalid vaccine doses. American journal of preventive medicine, 2004.PMID 14700710
- [22]GBD 2023 Vaccine Coverage Collaborators Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet (London, England), 2025.PMID 40578370
- [23]Hull B Immunisation Coverage Annual Report 2019. Communicable diseases intelligence (2018), 2021.PMID 33823758
- [24]Hull B Annual immunisation coverage report 2020. Communicable diseases intelligence (2018), 2022.PMID 36154654
- [25]Hull B Annual Immunisation Coverage Report 2022. Communicable diseases intelligence (2018), 2025.PMID 40925362
- [26]Law C Children overdue for immunisation: a question of coverage or reporting? An audit of the Australian Immunisation Register. Australian and New Zealand journal of public health, 2019.PMID 30959563
- [27]Giles ML How COVID-19 has impacted immunisation service delivery in Australia: a national study. Australian and New Zealand journal of public health, 2022.PMID 35616400
- [28]Davies C School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination. Vaccine, 2021.PMID 34127299
- [29]Wnukowski-Mtonga P Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable diseases intelligence (2018), 2020.PMID 32299331
- [30]Panovska-Griffiths J A method for evaluating and comparing immunisation schedules that cover multiple diseases: Illustrative application to the UK routine childhood vaccine schedule. Vaccine, 2018.PMID 30055970
- [31]Crowe S A novel approach to evaluating the UK childhood immunisation schedule: estimating the effective coverage vector across the entire vaccine programme. BMC infectious diseases, 2015.PMID 26714777
- [32]Sherman SM UK healthcare professionals' attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration. Vaccine, 2024.PMID 38480101
- [33]Bell KN Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics, 2001.PMID 11389298
- [34]Kenigsberg TA Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines. Vaccine, 2023.PMID 37599140
- [35]Lesinski GB Vaccines against polysaccharide antigens. Current drug targets. Infectious disorders, 2001.PMID 12455405
- [36]Bröker M Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations. Vaccine, 2017.PMID 28487056
- [37]Akkoyunlu M State of pneumococcal vaccine immunity. Human vaccines & immunotherapeutics, 2024.PMID 38567485
- [38]Armstrong GL The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics, 2007.PMID 17200247
- [39]Abbas K Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. The Lancet. Global health, 2020.PMID 32687792
- [40]Fine PEM Population Immunity and Polio Eradication. Pathogens (Basel, Switzerland), 2024.PMID 38535527